LA JOLLA PHARMACEUTICAL CO (14)
Browse by Contract Category
Contracts
-
Description of Securities
(Filed With SEC on March 9, 2022)
-
Amended Employment Offer Letter by and between La Jolla Pharmaceutical Company and Larry Edwards
(Filed With SEC on November 4, 2021)
-
License Agreement, dated as of August 3, 2006, by and between the Registrant and the President and Fellows of Harvard College, as amended
(Filed With SEC on March 8, 2021)
-
Contingent Value Rights Agreement, dated as of July 17, 2020, between La Jolla Pharmaceutical Company and American Stock Transfer & Trust Company, LLC, as Rights Agent
(Filed With SEC on July 29, 2020)
-
Agreement and Plan of Merger by and among the La Jolla, Merger Sub and Tetraphase, dated June 24, 2020
(Filed With SEC on June 24, 2020)
-
Form of Indemnification Agreement
(Filed With SEC on March 2, 2020)
-
PAION AG Exclusive Licensing Agreement, dated January 12, 2021
(Filed With SEC on March 8, 2021)
-
Amendment, dated as of December 5, 2017, by and between the Registrant and the President and Fellows of Harvard College, as amended
(Filed With SEC on March 8, 2021)
-
Employment Offer Letter by and between La Jolla Pharmaceutical Company and Larry Edwards dated as of July 28, 2020
(Filed With SEC on November 9, 2020)
-
Form of Contingent Value Rights Agreement, by and between La Jolla and the Rights Agent
(Filed With SEC on June 24, 2020)
-
Form of Support Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the stockholder named therein
(Filed With SEC on June 24, 2020)
-
Form of Exchange Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the holder named therein
(Filed With SEC on June 24, 2020)
-
Description of Securities
(Filed With SEC on March 2, 2020)
-
Employment Offer Letter by and between La Jolla Pharmaceutical Company and Darryl Wellinghoff dated as of February 25, 2019
(Filed With SEC on March 2, 2020)